Phase I therapeutic testing of viral-vectored vaccines that shift CD8+ T cell immunodominance to conserved regions of HIV-1- The CM Study
Research Grant
Awarded By
University of North Carolina - Chapel Hill
Start Date
February 1, 2022
End Date
June 30, 2025
Awarded By
University of North Carolina - Chapel Hill
Start Date
February 1, 2022
End Date
June 30, 2025